cancer metabolic adaptation

With five-year survival rates for metastatic breast cancer still below 30%, breakthroughs in both understanding and treatment are needed urgently. During Breast Cancer Awareness Month, we pay tribute to the dedicated scientists working at critical stages of the drug discovery and manufacturing pipeline. Breast cancer remains the most common malignancy in women worldwide, and a …